# Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)

> **NCT02039986** · — · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 13 (actual)

## Conditions studied

- Cystic Fibrosis Related Diabetes
- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02039986
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-06
- **Primary completion:** 2016-10-11
- **Final completion:** 2016-10-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039986, "Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02039986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*